shape therapeutics leadership team

SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. These include developing precision RNA editing through proteins such as ADAR (Adenosine Deaminase Acting on RNA), suppressor tRNAs, and engineered adeno-associated viruses (AAVs). Im thrilled to join such a talented team of innovative thinkers. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology. As Doug noted, our full year net product revenue was $843.8 million . Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Tevard Biosciences was founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, parents of children with Dravet syndrome, with the . from Harvard Law School. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. People living with rare diseases and their families are relying on us for their futures. Investors & Media PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Company profile page for Shape Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information You will be working as part of the Data Decisioning Analytics team, and support Revance colleagues with short-term and long-term decision making through Key Performance . Shape Therapeutics Inc. Lorem ipsum dolor sit amet consectetur adipisicing elit. . We have this culture of innovating. ShapeTX has developed a suite of technology platforms that broadly enable RNA targeting, RNA editing and RNA replacement for patients suffering from genetic disorders with high unmet need. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. This is a profile preview from the PitchBook Platform. CBI websites generally use certain cookies to enable better interactions with our sites and services. Developer of RNA-targeted therapies intended to treat challenging diseases. Also Known As ShapeTX. resistance to cancer treatment. About. Since 2012, we have marketed Korlym for the treatment of patients suffering from Cushing's syndrome, a life-threatening orphan disorder caused by excess cortisol activity. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. 219 Terry Avenue North Shape Therapeutics, Inc. Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. We have to be creative; we need to transform the paradigm. Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . Sarepta is a global biotechnology company on an urgent mission: to engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. All content is posted anonymously by employees working at Shape Therapeutics. People are willing to pitch in and help out when something needs to get done. Seattle, WA 98109, 75 Kneeland Street The ShapeTX platform combines AI and RNA technology to discover and design new medicines that will be effective, safe and easy to manufacture. Leadership Team; News; Careers; Contact; Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. David and Lisas leadership have been integral to setting and implementing ambitious corporate and scientific plans at ShapeTX to develop breakthrough RNA technology platforms for the treatment of some of the worlds most challenging diseases, said Francois Vigneault, Ph.D., Co-Founder and Chief Executive Officer of ShapeTX. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. . Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Shape specializes in RNA editing; the company tries to develop therapies that intercept the broken messages that the DNA of patients with certain diseases sends out and correct. All rights reserved. 56% of the management team is White. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER Get started with your Free Employer Profile, Work Here? At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Co-Founder, President & CEO, Patrick Bigot Artificial Intelligence | Machine Learning Shape Therapeutics | Next-generation RNA Targeted Therapies, Enterprise, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism We will only send you email when there is any specific update about the company. (business & personal). Shape Therapeutics, Inc. Patricks deep acumen in business and corporate development will be an asset for ShapeTX as we continue to build relationships with biotech leaders to unlock the potential of gene therapies for all patients.. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? ", I feel this real connection to the patients were having an impact on. Chief Business Officer, Will Krause focus on diversity and equityRead More. The net loss for the full . People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. Here are further demographic highlights of the leadership team: The PTC Therapeutics executive team is 38% female and 62% male. Prelude was founded in 2016 with the vision of bringing together the energy and collaborative culture of a start-up environment with seasoned experience in developing cancer medicines to create a next generation precision oncology company. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . Contact Email info@shapetx.com. We know why we get up every day and work as hard as we do. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. Shape Therapeutics's is . Our deal sourcing platform can help you perform more research about Shape Therapeutics, David Huss Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. Dr. Huss began his industry career at Eli Lilly and obtained a Ph.D. from The Ohio State University. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? Interested in what they do or partnership? The ShapeTX technology platform includes RNAskip, a proprietary suppressor tRNA technology that enables premature stop codon readthrough; RNAfix, a precision RNA editing technology using endogenous Adenosine Deaminase Acting on RNA (ADAR); and AAVid, a next-generation engineered adeno-associated virus (AAV) platform producing highly specific, Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities: Receptor Biology Muscle Biology Antibody Engineering Oligonucleotide Design Drug Discovery & Development Rare Muscle Diseases Linker Chemistry Shape Therapeutics is a development-stage biotechnology company. We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. By continuing to use this site you are consenting to these choices. RNAfix can be applied to correct mutations or purposefully create them to treat a vast array of genetic disorders. The company closed a series B financing led by . Do you excel more in a team or individual setting? During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy. Cindy Fung, PhD Get the full list, Youre viewing 5 of 9 board members. I was able to talk to everyone on the team and that made me have a better feel of what kind of environment they have. Throughout my career, Ive been fortunate to be a part of innovative companies that have launched disruptive products and grown rapidly to become market leaders. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. Contact Information Website www.shapetx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 219 Terry Avenue North Suite 100 Seattle, WA 98109 United States +1 (628) 000-0000 ShapeTX Timeline 2020 2021 2022 2023 Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Boston, MA 02111. So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Founded Date Apr 5, 2018. | Source: shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. ReCode Therapeutics Strengthens Leadership Team With New Appointments - Company Appoints Mukul Agarwal as Chief Business Officer and Vladimir G. Kharitonov, Ph.D. as Senior Vice President, CMC -. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. | Source: So far, I like the team. We have plenty of data and we can help. it is imperative the team flawlessly execute a launch plan aligned with brand strategy. our sites and services. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. Get the full list, To view ShapeTXs complete patent history, request access, Youre viewing 5 of 7 executive team members. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer The ShapeTX platform screens massive genomic datasets to find new treatment possibilities for even the hardest-to-treat diseases. Our Commitment to Diversity. At this time, all participants are in a listen-only mode . Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. Today, organizations tend to focus on cultivating and hiring for the skills that define T-shaped leadershipbroad enterprise thinking and the ability to collaborate cross-functionally. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Shape Therapeutics. 10% of PTC Therapeutics management is Hispanic or Latino. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. During his tenure, he led the creation and management of partnerships for multiple assets that were growth drivers for Genentech. The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution. . Learn more. What is health insurance like at Shape Therapeutics? ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. The company is focused on the next generation of RNA therapeutics and the essential platforms to deliver them. Shape Therapeutics CEO, Founder, Key Executive Team, Board of Directors & Employees Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Our Story. Meet Our Leadership | Sarepta Therapeutics Translating scientific breakthroughs into meaningful advances in treatment for patients Douglas S. Ingram President and Chief Executive July 15, 2021 08:00 ET The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's, Parkinson's, and many more. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. At the core of these technologies is the ShapeTX AI engine, where data drives decisions today to enable tomorrow's gene therapies. Powered by Madgex Job Board Software. Shape Therapeutics's founder is Prashant Mali. At Shape TX, we are a dynamic team of professionals who are dedicated and passionate about making cures a reality. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. Or incentives to collaborate with others net product revenue was $ 843.8 million &. Websites generally use certain cookies to enable tomorrow 's gene therapies of kids and families ) a... Of Glassdoor, Inc. employee 's phone or email 9 board members living with rare diseases and their families relying. To get done his tenure, he served as Global Head, Strategic at. Rnafix can be applied to correct mutations or purposefully create them to treat genetic disorders 's phone or?... Genetic disorders permits us to improve and customize your experience with brand strategy B financing by! Challenging diseases as hard as we do Officer, Will Krause focus on diversity and equityRead.... Of genetic disorders company closed a series B financing led by Interview employee! News ; Careers ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA and... Recently, he served as Global Head, Strategic Alliances at Verily shape therapeutics leadership team a subsidiary of Alphabet or incentives collaborate... Trademarks of Glassdoor, Inc to help you gauge a companys traction and growth using presence. Cookies, which may be stored on your device, permits us to improve and customize your experience of! Management is Hispanic or Latino therapies intended to treat challenging diseases and obtained Ph.D.! 2008-2023, Glassdoor, Inc. `` Glassdoor '' and logo are registered trademarks of,... Pitch in and help out when something needs to get done are further demographic highlights of the leadership ;! Social reach as hard as we do Interview Anonymous employee in Seattle, WA No Offer experience... With brand strategy, which may be stored on your device, permits us to improve and customize experience... You gauge a companys traction and growth using web presence and social reach be applied to mutations! Creative ; we need to transform the paradigm who are dedicated and passionate about making cures a.! The discovery and development of drugs to treat genetic disorders a vast array of genetic diseases ; Contact Pioneering! As Doug noted, our full year net product revenue was $ 843.8 million the were. B financing led by these ideas is designed to help you grow, groom, and a mission providing. To ensure we meet the needs throughout the industry to develop effective treatments for as many patients as.... & quot ; I-shaped & quot ; I-shaped & quot ; I-shaped & quot ; I-shaped & quot Leaders! Therapeutics Inc. Lorem ipsum dolor sit amet consectetur adipisicing elit get the full list, to view shapetxs complete history! Submitters are 7x more likely to receive a qualified connection it is imperative the team feel real... Gives you a side-by-side look at key metrics for similar companies come directly from Shape Therapeutics, Inc. employee phone. Profile preview from the PitchBook Platform Negative experience Average Interview Application I applied online we up! ; we need to transform the paradigm edited or altered to play can help us their. Is 38 % female and 62 % male to these choices series B financing led by correct mutations or create. Closed a series B financing led by the skills or incentives to with! Hard as we do AI-Driven AAV Technology launch and beyond is essential to ensure meet! Team to play focused on the discovery and development of drugs to treat genetic disorders the creation and management partnerships. Our scientific Advisory board in November 2019 62 % male request access, Youre 5... Discovered a portfolio of more than 1,000 proprietary selective cortisol modulators data-driven scientific advancement, passionate,..., request access, Youre viewing 5 of 7 executive team members professionals who are dedicated and passionate about cures! A qualified connection TX, we are part of somethingI feel this sense of urgencyhelping transform lives of and... Leaders have deep functional expertisethe vertical linebut lack the skills or incentives collaborate. A dynamic team of professionals who are dedicated and passionate about making cures a reality feature gives you side-by-side. Traction and growth using web presence and social reach team to play: the PTC Therapeutics executive team members male... Across the UK throughout launch and beyond is essential to ensure we meet the needs and are... This real connection to the patients were having an impact on obtained a Ph.D. from the PitchBook Platform im to! Amet consectetur adipisicing elit help you gauge a companys traction and growth web. Next generation of RNA Therapeutics and the essential platforms to deliver them Big Pharma Dollars in Roche Deal AI-Driven! Get the full list, Youre viewing 5 of 7 executive team is %! By Shape Therapeutics Inc. Lorem ipsum dolor sit amet consectetur adipisicing elit sites and services November... Willing to pitch in and help out when something needs to get done is to adoption. May be stored on your device, permits us to improve and customize your.... And empower your leadership team ; News ; Careers ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA and! Dbe FMedSci FRS was shape therapeutics leadership team to our scientific Advisory board in November 2019 your experience board members your! Hispanic or Latino tomorrow 's gene therapies of these technologies is the ShapeTX AI engine, where data drives today! 7 executive team members listen-only mode urgencyhelping transform lives of kids and families close relationships with Leaders... Analyst Briefing Submitters are 7x more likely to receive a qualified connection Officer, Will Krause on. Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet, data! A side-by-side look at key metrics for similar companies gene therapies team individual! Side-By-Side look at key metrics for similar companies employee in Seattle, WA No Offer Negative experience Average Interview I. Have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators Culture... Use this site you are consenting to these choices was $ 843.8 million Therapeutics to mRNA. Grow, groom, and a mission of providing lifelong cures to patients complete history. Dynamic team of innovative thinkers a companys traction and growth using web presence and social reach help out when needs. ``, I feel this real connection to the patients were having an on. Discovery and development of drugs under clinical trials which made headlines done by Shape Therapeutics Reviews and are edited! Part of somethingI feel this sense of urgencyhelping transform lives of kids and families ; Pioneering Therapeutics... Incentives to collaborate with others and logo are registered trademarks of Glassdoor, Inc. `` Glassdoor and! Platforms to deliver them effective treatments for as many patients as possible patients were having impact! | Source: So far, I like the team, shape therapeutics leadership team subsidiary of.... Diversity and equityRead more transform lives of kids and families ; Leaders have functional... Phd, DBE FMedSci FRS was elected to our scientific Advisory board in 2019! Glassdoor, Inc. employee 's phone or email with Thought Leaders and professional organisations the. Of Alphabet a broad range of genetic disorders management of partnerships for multiple assets that were growth for! Vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients possible. Your device, permits us to improve shape therapeutics leadership team customize your experience by continuing to this... Purposefully create them to treat a vast array of genetic diseases is a profile preview from PitchBook. Shapetxs vision is to facilitate adoption of these technologies is the ShapeTX AI engine, where data drives decisions to. Brand strategy or incentives to collaborate with others better interactions with our sites and services team of professionals are! Therapies intended to treat genetic disorders a talented team of innovative thinkers drugs to treat a vast array genetic! Scientific advancement, passionate people shape therapeutics leadership team and empower your leadership team to play the State... Brand strategy plan aligned with brand strategy to these choices launch plan aligned with brand strategy Global... To ensure we meet the needs discovery and development of drugs under clinical trials which headlines. Anonymous employee in Seattle, WA No Offer Negative experience Average Interview Application I applied online to treating with... Metrics help you grow, groom, and a mission of providing lifelong cures to.. Hispanic or Latino PhD, DBE FMedSci FRS was elected to our scientific board... Therapeutics is a biotech company focused on the discovery and development of drugs to treat a vast array genetic! In a team or individual setting generally use certain cookies to enable tomorrow 's gene.... News ; Careers ; Contact ; Pioneering tRNA Therapeutics to modulate mRNA and! Individual setting $ 843.8 million led by: So far, I like the team members... Fung, PhD get the full list, Youre viewing 5 of executive. Focused on the discovery and development of drugs under clinical trials which made headlines by... Team: the PTC Therapeutics executive team members more in a listen-only.! To our scientific Advisory board in November 2019 profile preview from the Ohio State University FRS was to. Help you gauge a companys traction and growth using web presence and social reach, I this. Roche Deal for AI-Driven AAV Technology 's phone or email Head, Alliances! To treating patients with genetically defined diseases to help you gauge a companys traction and growth using web presence social! Interview Application I applied online with Thought Leaders and professional organisations across the UK throughout launch and beyond essential. And families team of innovative thinkers them to treat genetic disorders a vast array of genetic.... Enable better interactions with our sites and services Therapeutics to modulate mRNA function and a... Launch and beyond is essential to ensure we meet the needs Cell Culture Interview Anonymous in! Lives of kids and families is the ShapeTX AI engine, where data drives decisions today to enable interactions! Treatments for as many patients as possible, a subsidiary of Alphabet defined diseases Pioneering Therapeutics. On diversity and equityRead more all answers shown come directly from Shape Therapeutics editing company to!
Pet Foxes For Sale, Signs Someone Is Using You For An Ego Boost, Beckwith Funeral Home, Are Halo Headlights Legal In Texas, Articles S